Reply

J M Chi¹, M Mackay², A Hoang³, K Cheng¹, C Aranow², J Ivanidze⁴, B Volpe⁵, B Diamond⁶, P C Sanelli^{7

8}

Affiliations

¹ Department of Radiology.
² Feinstein Institute for Medical Research The Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hempstead, New York.
³ Department of Radiology Northwell Health New York, York.
⁴ Department of Radiology Weill Cornell Medical College New York, New York.
⁵ Feinstein Institute for Medical Research The Center for Biomedical Science.
⁶ Feinstein Institute for Medical Research The Center for Health Innovations and Outcomes Research.
⁷ Feinstein Institute for Medical Research The Center for Health Innovations and Outcomes Research Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hempstead, New York.
⁸ Department of Radiology Imaging Clinical Effectiveness and Outcomes Research Program Northwell Health New York, New York.

Comment

J M Chi et al. AJNR Am J Neuroradiol. 2019 Aug.

. 2019 Aug;40(8):E42-E43.

doi: 10.3174/ajnr.A6166. Epub 2019 Jul 25.

J M Chi¹, M Mackay², A Hoang³, K Cheng¹, C Aranow², J Ivanidze⁴, B Volpe⁵, B Diamond⁶, P C Sanelli^{7

8}

¹ Department of Radiology.
² Feinstein Institute for Medical Research The Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hempstead, New York.
³ Department of Radiology Northwell Health New York, York.
⁴ Department of Radiology Weill Cornell Medical College New York, New York.
⁵ Feinstein Institute for Medical Research The Center for Biomedical Science.
⁶ Feinstein Institute for Medical Research The Center for Health Innovations and Outcomes Research.
⁷ Feinstein Institute for Medical Research The Center for Health Innovations and Outcomes Research Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hempstead, New York.
⁸ Department of Radiology Imaging Clinical Effectiveness and Outcomes Research Program Northwell Health New York, New York.

No abstract available

Comment on

Alterations in Blood-Brain Barrier Permeability in Patients with Systemic Lupus Erythematosus.
Chi JM, Mackay M, Hoang A, Cheng K, Aranow C, Ivanidze J, Volpe B, Diamond B, Sanelli PC. Chi JM, et al. AJNR Am J Neuroradiol. 2019 Mar;40(3):470-477. doi: 10.3174/ajnr.A5990. Epub 2019 Feb 21. AJNR Am J Neuroradiol. 2019. PMID: 30792254 Free PMC article.
Blood-Brain Barrier Permeability in Patients with Systemic Lupus Erythematosus.
Lecler A, Sadik JC, Savatovsky J. Lecler A, et al. AJNR Am J Neuroradiol. 2019 Aug;40(8):E41. doi: 10.3174/ajnr.A6137. Epub 2019 Jul 25. AJNR Am J Neuroradiol. 2019. PMID: 31345948 Free PMC article. No abstract available.

1. Sourbron SP, Buckley DL. On the scope and interpretation of the Tofts models for DCE-MRI. Magn Reson Med 2011;66:735–45 10.1002/mrm.22861 - DOI - PubMed
1. Bergamino M, Saitta L, Barletta L, et al. . Measurement of blood-brain barrier permeability with T1-weighted dynamic contrast-enhanced MRI in brain tumors: a comparative study with two different algorithms. ISRN Neurosci 2013;2013:905279 10.1155/2013/905279 - DOI - PMC - PubMed
1. Lecler A, Balvay D, Cuenod CA, et al. . Quality-based pharmacokinetic model selection on DCE-MRI for characterizing orbital lesions. J Magn Reson Imaging. 2019. April 15. [Epub ahead of print] 10.1002/jmri.26747 - DOI - PubMed
1. Heye AK, Thrippleton MJ, Armitage PA, et al. . Tracer kinetic modelling for DCE-MRI quantification of subtle blood-brain barrier permeability. Neuroimage 2016;125:446–55 10.1016/j.neuroimage.2015.10.018 - DOI - PMC - PubMed
1. Thrippleton MJ, Backes WH, Sourbron S, et al. . Quantifying blood-brain barrier leakage in small vessel disease: review and consensus recommendations. Alzheimers Dement 2019;15:840–58 10.1016/j.jalz.2019.01.013 - DOI - PMC - PubMed